Cellular Biomedicine Group (CBMG) boosts development of CAR-T and Stem Cell therapies – Scientific Computing World
|
Cellular Biomedicine Group (CBMG) boosts development of CAR–T and Stem Cell therapies
Scientific Computing World CBMG and GE Healthcare Life Sciences China plan to develop state-of-the-art automated CAR–T and stem cell manufacturing capabilities that build upon the accreditation of CBMG's GMP facilities in Shanghai, Wuxi and Beijing. The co-development activity … |
